Use of Botulinum Toxin in patients with temporomandibular disordes: An integrative review




Temporomandibular joint; Temporomandibular joint dysfunction; Botulinum toxin; Dentistry.


The literature defines Temporomandibular Disorder (TMD) as a set of disorders that affect the masticatory muscles, the temporomandibular joint and associated structures. When properly diagnosed, most patients with TMD respond favorably to conservative, reversible and affordable treatment. Botulinum toxin is a non-invasive procedure, with quick results, compared to invasive treatments, has a safe composition, has good prognoses and has a scientific basis when used in the dental area as a functional and aesthetic treatment, especially in the area of TMD. Thus, the objective of this study was to identify, through scientific publications, the application of botulinum toxin in the treatment of temporomandibular disorders. This is a literature review. The search took place from September 26th to November 6th, 2023, in the databases: PubMed and Scielo. According to the articles that supported this study, TMD is multifactorial and has received attention from different health professionals, such as orthopedists, neurologists, psychiatrists, otorhinolaryngologists, psychologists and physiotherapists. It was considered that the application of botulinum toxin type A to the muscles associated with MRD aims to temporarily reduce local muscle activity, inhibiting the release of the neurotransmitter acetylcholine at the neuromuscular junction, providing relief and comfort to the patient.


Ataran, R., Bahramian, A., Jamili, Z., Pishahang, V., Barzegani, H. S., Sarbakhsh, P., & Yazdani, J. (2017).The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review. Dent Shiraz Univ Med Sci. 8(3),157-164.

Benini, G. R. (2017). O uso da toxina botulínica no tratamento da DTM muscular. Journal of Applied Oral Science. 22(1), 15- 21.

Calis, A. S., Colakoglu, Z., & Gunbay, S. (2019). The use of botulinum toxin-a in the treatment of muscular temporomandibular joint disorders. Journal of Stomatology, Oral and Maxillofacial Surgery 4(1), 24-31.

Calixtre, L. B., Gruninger, B. L. S., Chaves, T. C., & Oliveira, A. B. (2015). Is there na association between anxiety / depression and temporomandibular disorders in college studentes? J. Appl Oral Scl. 23(2), 15-22.

Caruso, S., Storti, E., Nota, A., Ehsani, S., & Gatto, R. (2017). Temporomandibular Joint Anatomy Assessed by CBCT Images. BioMed Research International. 17(1), 53-60.

Couto, A. P. G. R., Freire, L. F. S., & Moraes, J. C. (2022). O uso da toxina botulínica tipo A como alternativa terapêutica na disfunção temporomandibular: uma revisão de literatura. Reas. 15(8), 1-11.

Dalacqua, J. L. V., Arantes, A. P. F. (2022). Utilização da toxina botulínica no tratamento de disfunção temporomandibular e bruxismo. 1(2), 26-37.

Dias, R., & Fonseca, J. (2016). Disfunções Temporomandibulares (DTM): Introdução e Classificação. In: Almeida, A. M., Fonseca, J., & Félix, S. Dor orofacial e disfunções temporomandibulares: Tratamento farmacológico. 17-26.

Ferreira, C. L. P., Silva, M. A. M. R., & Felício, C. M. (2015). Sinais e sintomas de desordem temporomandibular em mulheres e homens. Codas. 28(1):17-21.

Gonçalves, G., Suguihara, R. T., & Muknicka, D. P. (2023). Toxina botulínica na disfunção temporomandibular. Research, Society and Development. 12(14), 45-52.

Kakkolla, O. (2018). Efficacy of stabilisation splint treatment on the oral health-related quality of life-A randomised controlled one-year follow-up trial. J Oral Rehabil, 45(5), 355- 362.

Kucukguven, A., et al. (2021). A Novel Injection Technique to the Lateral Pterygoid Muscle for Temporomandibular Disorders: A Cadaveric Study. Plastic and Reconstructive Surgery, 148(5), 785e–790.

Naked, S., Vieira, E. O., Ramos, L. N. N., Marchesini, M. M., & Ramos, D. N. N. (2017). Toxina botulínica tipo A na disfunção temporomandibular. Rev Flum Odont. 47(2), 16-23.

Olender, D. (2021). Botulinum toxin application in the treatment of anterior disc displacement in TMJ – review of literature. Prosthodontics, 68(2), 223-231.

Rizzolo, R., & Madeira, M. (2014). Anatomia Facial com fundamentos de anatomia sistêmica geral. Sarvier. 508- 519.

Santos, L. R., & Beck, D. G. T. S. (2017). Alterações posturais da coluna cervical no desenvolvimento das disfunções temporomandibulares, Rev. Saúde Integrada. 10(9), 40-50.

Souza, M. T., Silva, M. D., & Carvalhoa, R. (2018). Revisão integrativa: o que é e como fazer? Einstein. 8(1), 102- 6.

Souza, N. C. (2018). Disfunções temporomandibular relacionadas a postura global. Faculdades Integradas de Bauru – FIB. 3(1), 4-11.

Thambar, S., et al. (2020). Botulinum toxin in the management of temporomandibular disorders: a systematic review. The British Journal of Oral & Maxillofacial Surgery, 58(5), 508–519.

Ting, P., & Freiman, A. (2017). “The story of Clostridium botulinum: from food poisoning to BOTOX”-review. Clinical Medicine: Journal of the Royal College of Physicians of London, 4(3), 258–261.

Velázquez, M. F., et al. (2019). Desarrollo de miastenia gravis tras administración de toxina botulínica en el síndrome de dolor miofascial. Rev Soc Esp Dolor, 22(3), 102-105.

Zavaneli, A. C., et al. (2018). Abordagem, diagnóstico e tratamento das disfunções temporomandibulares – relato de caso.Arch Health Invest, 7(12), 523-529.



How to Cite

LIMA, J. A. de; HOLANDA, L. M. C. da S. .; OLIVEIRA, A. H. M. de . Use of Botulinum Toxin in patients with temporomandibular disordes: An integrative review. Research, Society and Development, [S. l.], v. 13, n. 1, p. e5713144464, 2024. DOI: 10.33448/rsd-v13i1.44464. Disponível em: Acesso em: 22 jun. 2024.



Health Sciences